DDX3X and breast carcinoma: Similarly, we have recently observed that women whose breast cancers have low DDX3X gene expression had significantly better prognosis (Log-Rank test’s p-value < 0.01) than the group with high expression (Figure S1), thus supporting a specific prognostic role for DDX3X in these tumor types.